1. Home
  2. AQST vs BYM Comparison

AQST vs BYM Comparison

Compare AQST & BYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • BYM
  • Stock Information
  • Founded
  • AQST 2004
  • BYM 2002
  • Country
  • AQST United States
  • BYM United States
  • Employees
  • AQST N/A
  • BYM N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • BYM Investment Managers
  • Sector
  • AQST Health Care
  • BYM Finance
  • Exchange
  • AQST Nasdaq
  • BYM Nasdaq
  • Market Cap
  • AQST 272.9M
  • BYM 270.7M
  • IPO Year
  • AQST 2018
  • BYM N/A
  • Fundamental
  • Price
  • AQST $2.71
  • BYM $10.48
  • Analyst Decision
  • AQST Strong Buy
  • BYM
  • Analyst Count
  • AQST 5
  • BYM 0
  • Target Price
  • AQST $11.40
  • BYM N/A
  • AVG Volume (30 Days)
  • AQST 1.7M
  • BYM 60.2K
  • Earning Date
  • AQST 05-12-2025
  • BYM 01-01-0001
  • Dividend Yield
  • AQST N/A
  • BYM 4.49%
  • EPS Growth
  • AQST N/A
  • BYM N/A
  • EPS
  • AQST N/A
  • BYM N/A
  • Revenue
  • AQST $54,228,000.00
  • BYM N/A
  • Revenue This Year
  • AQST N/A
  • BYM N/A
  • Revenue Next Year
  • AQST $40.62
  • BYM N/A
  • P/E Ratio
  • AQST N/A
  • BYM N/A
  • Revenue Growth
  • AQST 5.29
  • BYM N/A
  • 52 Week Low
  • AQST $2.12
  • BYM $9.30
  • 52 Week High
  • AQST $5.80
  • BYM $11.77
  • Technical
  • Relative Strength Index (RSI)
  • AQST 54.01
  • BYM 47.79
  • Support Level
  • AQST $2.22
  • BYM $10.32
  • Resistance Level
  • AQST $2.79
  • BYM $10.50
  • Average True Range (ATR)
  • AQST 0.19
  • BYM 0.10
  • MACD
  • AQST 0.04
  • BYM -0.00
  • Stochastic Oscillator
  • AQST 75.64
  • BYM 45.00

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About BYM Blackrock Municipal Income Quality Trust of Beneficial Interest

Blackrock Municipal Income Quality Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from U.S. federal income taxes, including the alternative minimum tax. The trust invests in various sectors such as transportation, utilities, health, education, corporate, housing, and others.

Share on Social Networks: